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Background and Aims: Diabetic nephropathy is one of the leading causes of end 
stage renal disease (ESRD)  in the world. This study was conducted to investigate the 
correlation of  B12 deficiency with presence of proteinuria in patients with Diabetes 
Mellitus.
Materials and Methods: This study was performed on patients with type 2 Diabetes 
Mellitus. The inclusion criteria were: HbA1C ≤8%, absence of hypertension or con-
trolled blood pressure (BP<140/90) in hypertensive patients, no smoking, absence of 
any recent stressful illness such as MI, CVA and causes of proteinuria other than dia-
betic nephropathy. The serum level of B12 and the amount of urine protein–to-creati-
nine ratio (UPCR) were measured, and correlation between b12 deficiency and pres-
ence of proteinuria was assessed using Spearman correlation test. 
Results: In this study 78 patients (44.87% women and 55.13% men) were examined. 
There was an inverse and weak correlation between the serum B12 deficiency and 
presence of proteinuria (r=-0.104), which was not statistically significant (p=0.254). 
Due to the statistically significant difference between two groups with and without pro-
teinuria in antiproteinuric drugs, as well as Metformin use and chronic kidney disease 
(CKD) stage, a subgroup analysis was performed in each of these subgroups. There 
was no correlation between the B12 deficiency and presence of proteinuria.
Conclusion: The findings  revealed no statistically significant correlation between the 
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Diabetes is known as a common non-communicable disease 
in various societies. This disease affects various organs. 
One of the complications of diabetes is nephropathy [1]. 
Diabetic nephropathy is the cause of 30-50% of the ESRD 
cases in the United States. The clinical presentation of di-
abetic nephropathy is defined as proteinuria, hypertension, 
and progressive decline in renal function. The growth fac-
tors, hemodynamic and hormonal changes cause the release 
of inflammatory factors and reactive oxygen species which 
cause glomerular hyperfiltration, renal hypertrophy and al-
tered glomerular composition that presents clinically with 
albuminuria and hypertension [1]. The care and treatment 
suggested so far (including controlling blood sugar, lipids, 
blood pressure, and prescribing  drugs such as angiotensin 
converting enzyme inhibitors (ACEI)  and  angiotensin re-
ceptor blockers (ARB) were inadequate to treat diabetic ne-
phropathy and other unknown factors seem to be effective 
in causing diabetic nephropathy [1, 2].
In diabetic patients, the serum level of B vitamins is re-
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luminescence  (ECL) method. The patients were instruct-
ed not to do too much physical activity before preparing a 
urine sample and rest for 10 minutes in a supine position. 
Random urine was taken from a patient to measure the level 
of creatinine and protein in the urine, urine protein, and cre-
atinine were measured by biochemical tests. The amount of 
proteinuria was calculated by measuring the ratio of protein 
to creatinine in random urine. GFR was calculated using the 
MDRD formula.
The data  were analyzed utilizing SPSS software version 
24 by spearman correlation coefficient, independent t and 
chi-square tests. p <0.05 is considered as a statistically sig-
nificant level in this study.
RESULTS
IIn this study, 300 patients with type 2 Diabetes Mellitus 
were studied, of which 78 patients were eligible for the 
study. The data of these 78 patients (35 females and 43 
males) with a mean age of   8/14±59years (minimum 26 
and maximum 87 years) were analyzed. 33(42.3%) patients 
had proteinuria and 45 (57.7%) patients had no proteinuria. 
There were 48 (61.5%) patients with hypertension, but all 
of them had controlled blood pressure at the time of the 
study. 51(65.4%) patients were treated with ACEI and ARB. 
61(78.2%) patients also took other protein-lowering drugs 
including Pentoxifylline, Atorvastatin, Gliclazide, Allo-
purinol, Indapamide, Dipyridamole, and Spironolactone. 
duced, but the mechanism of reduction is not entirely clear; 
nevertheless, one reason for the decrease can be long-term 
use of Metformin that reduces the absorption of vitamin 
B12 and folic acid from the gastrointestinal tract [3, 4]. In a 
cross-sectional study, 22% of patients with diabetes lacked 
B12 [2]. However, in another study of diabetic patients with 
or without nephropathy, vitamin B1 and B6 deficiency were 
common and vitamin B12 deficiency was rare [5]. Many 
patients with type 2 diabetes are treated with Metformin 
and the association between long-term use of Metformin 
and the B12 deficiency has been established. Although, 
there have been differences in the extent of this relationship 
in different studies; in one study, nearly 30% of diabetic 
patients treated with Metformin were deficient in vitamin 
B12 [6]. The decrease in the level of B vitamins, including 
B12, causes hyperhomocysteinemia, consequently, it caus-
es increasing oxidative stress and decreasing antioxidant 
function [7-9]. Therefore, considering the importance of 
recognizing the causes of diabetic nephropathy other than 
the known factors for the prevention of ESRD, we decided 
to investigate the link between vitamin B12 deficiency and 
proteinuria in patients with Diabetes Mellitus.
MATERIALS and METHODS
This study was approved by the ethical committee of Sha-
hid Beheshti medical university (IR.SBMU.RETECH.
REC.1398.424).This study was performed as a descrip-
tive correlation study in patients with type 2 
Diabetes Mellitus referred to Loghman Hakim 
Hospital. The patients were first explained 
about the study and its goals; the patients were 
included in the study with personal consent. 
The inclusion criteria were: HbA1C ≤8%,ab-
sence of hypertension or controlled blood pres-
sure (BP<140/90)in hypertensive patients, no 
smoking, absence of any  recent stressful ill-
ness such as MI, CVA and causes of proteinuria 
other than diabetic nephropathy such as acute 
febrile illness and kidney disease (glomerular 
or tubular). At first, a complete history of the 
patients was taken and a physical examination 
was performed. After 12 hours of fasting, 7 cc 
of blood was taken from the patients on an out-
patient basis and collected in three test tubes. 1 
cc in test tube containing EDTA anticoagulant 
for blood cell count, 1 cc in test tube containing 
EDTA anticoagulant for HbA1C, 5 cc in third 
test tube that was  centrifuged and the serum 
was removed. 0.5 cc of the serum was frozen 
at minus 20 ° C and was maintained to measure 
the serum B12 level and the remaining 4.5 cc 
was used to measure triglycerides, cholester-
ol, HDL, LDL, fasting blood sugar (FBS) urea 
and creatinine. Biochemical assays were used 
to measure triglycerides, cholesterol, HDL, 
LDL, FBS, urea, creatinine. The B12 level was 
measured by COBAS E411 and Electrochemi-
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Table 1. Demographic and clinical characteristics of patients (BMI= Body mass index, 
ARB= Angiotensin receptor blockers, ACEI= Angiotensin-converting enzyme inhibitors, 











Male 43 (55.1) 22 (66.7) 21 (46.7) 0.110
BMI (kg/m²) 
(mean± SD)
78 28.78±5.65 34.26±9.35 0.002
Hypertension 48 (61.5) 22 (66.7) 26 (57.8) 0.480
ARB/ACEI 
Consumption








14 (17.9) 7 (21.2) 7 (15.6) 0.561
Metformin 
consumption
36 (46.2) 9 (27.3) 27 (60) 0.006
eGFR 90≤ 2 (2.6) 0  (0) 2 (4.4)
0.002
60-89 22 (28.2)    4 (12.1) 18 (40)
30-59 40 (51.3) 18 (54.4) 22 (48.9)
15-29 9 (11.5) 6  (18.2)  3  (7/6)
<15 5  (6.4) 5 (15.2) 0 (0)
B12 deficiency 24 (30.77) 12 (36.4) 12 (26.7) 0.254
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The percentage of ACEI, ARB and other proteinuria-low-
ering drugs were higher in patients with proteinuria. There 
were 36(46.2%) patients treated with Metformin, of which 
15 (41.7%) patients had B12 deficiency (P = 0.054).Most 
patients had stage 2 (28.2%) and 3 (51.3%) CKD. More 
details about the demographic and clinical information of 
patients with comparison between the two groups with and 
without proteinuria are given in Table 1.
55.1% of patients (n = 43) had HbA1C below 7% and 
44.9% (n = 35) had 7-8 HbA1C. There was no significant 
difference between taking multivitamins containing B vita-
mins and the serum lipid level of the two groups with and 
without proteinuria (P> 0.05).
In this study, the serum B12 level was measured by ECL 
method with a normal level of 197-771 pg/ml. The values 
below 197 were considered as B12 deficiency. 30.8% of 
patients (n = 24) had B12 deficiency. 36.4% of patients 
with proteinuria and 26.7% of patients without proteinuria 
had B12 deficiency. The mean serum B12 level in patients 
with proteinuria was 377.2 ± 332.53 and in patients without 
proteinuria was082/283 ±63/294   . Using Spearman cor-
relation test, it was found that there is a weak inverse cor-
relation between the serum B12 level and proteinuria (r = 
-0.104) which was not statistically significant (p = 0.254). 
Due to the statistically significant difference between the 
two groups with and without proteinuria in the use of ACEI 
and ARB and other proteinuria reducing drugs as well as 
the use of metformin and CKD stage, subgroup analysis 
was performed and Spearman test indicated that the cor-
relation between proteinuria and the B12 level in each of 
the above subgroups was not statistically significant.
Other laboratory information of patients is given in detail 
in Table 2.
DISCUSSION
Diabetic nephropathy is one of the leading causes of ESRD 
in the world [1]. B12 deficiency has been suggested as one 
of the possible effective causes in the development and ac-
celeration of diabetic nephropathy [10]. Therefore, consid-
ering the importance of recognizing the factors affecting di-
abetic nephropathy for prevention and treatment, 
the aim of this study was to determine the correla-
tion between the serum B12 level and proteinuria 
in patients with Diabetes Mellitus which according 
to the results of this study, the correlation between 
the two was inverse, weak, and was not statistical-
ly significant. The consideration for the role of vi-
tamin B12 stems from the fact that the lack of this 
vitamin can increase oxidative stress by increas-
ing homocysteine and cause toxic effects [7,8]. 
But the question that needs to be answered first is 
whether there is a correlation between the serum 
B12 level and proteinuria that in the next step, if 
this correlation is proven, the effects of this vi-
tamin in the prevention and treatment of diabetic 
nephropathy should be investigated. In a study of 
100 Indian patients with type 2 diabetes, the B12 
level was significantly lower in the group with nephropathy 
than in the group without nephropathy [10], yet in a study 
conducted in the United States on 2965 patients, there was 
no correlation between the serum B12 level and albumin-
uria or decreased renal function [11]. However, this study 
has not been performed on diabetic patients; also, in another 
study performed on diabetic patients  in Germany, there was 
no significant relationship between the serum B12 level and 
albuminuria [5]. A study was conducted in 2010 to evaluate 
the effect of high doses of B vitamins (including folic acid, 
B6, and B12) on patients with nephropathy that at the end of 
treatment, not only proteinuria did not change significantly, 
but these patients had a greater decrease in GFR and a greater 
increase in MI and stroke than the control group [12]. There-
fore, lowering homocysteine by administering high doses of 
vitamin B12 was not necessarily associated with reducing 
the effects of hyperhomocysteinemia [13]. Therefore, there 
is currently no strong evidence to support the administration 
of  vitamin B12, to reduce diabetic nephropathy. 
One of the significant results in this study is the rate of B12 
deficiency in patients treated with Metformin (41.7%), which 
is higher than similar previous studies [2, 4]. This indicates 
the need to pay more attention to the evaluation of patients 
treated with metformin for B12 deficiency.
LIMITATIONS and SUGGESTIONS
One of the limitations of this study is the small number of 
samples and another limitation is the lack of measurement 
of the serum levels of methylmalonic acid and homocyste-
ine. Thus, our suggestion is to conduct a study with a large 
number of sample volumes in this field, and in addition to 
the serum B12 level, the serum level of Methylmalonic Acid 
and homocysteine should also be measured. CONFLICT
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Serum Vitamin B12 (pg/ml) 377.12±332.53 294.63±283.082 0.254
Hemoglobin (g/dl) 12.712±1.965 13.309±1.44 0.333
Triglyceride (mg/dl) 139.06±111.85 141.49±59.14 0.910
Cholestrole (mg/dl) 135.52±33.46 150.27±36.84 0.069
HDL (mg/dl) 41.69±10.77 40.08±8.87 0.483
LDL (mg/dl) 73.78±26.67 85.84±31.45 0.071
Creatinin (mg/dl) 2.25±1.62 1.25±0.415 0.001
FBS (mg/dl) 118.27±45.08 131.3±34.75 0.172
eGFR (ml/min/1.73 m²) 37.74±18.47 57.12±17.23 0.000
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